TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Stock
Certificat
DE000SU52N14
| Real-time Boerse Frankfurt Warrants 09:22:08 2024-07-12 am EDT | ||
| 25.55 EUR | -2.22% |
|
| Current month | -7.64% | ||
| 1 month | -3.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 25.55 | -2.22% |
| 24-07-11 | 26.13 | -0.83% |
| 24-07-10 | 26.35 | -1.42% |
| 24-07-09 | 26.73 | -1.18% |
| 24-07-08 | 27.05 | -2.42% |
Real-time Boerse Frankfurt Warrants
Last update July 12, 2024 at 09:22 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SU52N1 |
| ISIN | DE000SU52N14 |
| Date issued | 2023-12-20 |
| Strike | 772.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 33.64 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 35.84 € |
|---|---|
| Lowest since issue | 25.52 € |
| Spread | 0.27 € |
| Spread % | 1.05% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
492.1
USD
Average target price
473.1
USD
Spread / Average Target
-3.87%
- Stock Market
- Certificates
- Certificat
